TY - JOUR
T1 - Effect of the Photodynamic Therapy Applications with Potent Microalgae Constituents on Several Types of Tumor
AU - Jabeen, A.
AU - Reeder, B.
AU - Svistunenko, D.
AU - Hisaindee, S.
AU - Ashraf, Syed
AU - Al-Zuhair, S.
AU - Battah, S.
N1 - Funding Information:
This work has been supported by:
Publisher Copyright:
© 2018 AGBM
PY - 2019/2
Y1 - 2019/2
N2 - Background: In recent years, microalgae (MA) have attracted much interest considering their possible therapeutic application. They contain active natural compounds or derivatives (extracts, pure or chemically modified compounds) that have increasing applications in the pharmaceutical industry. Methods: The present study aims to examine microalgae for new photosensitizers, with a potential to be used in the light-associated treatment of tumors. Semi-purified extracts of several microalgae strains were evaluated as photosensitizers for photodynamic therapy (PDT) applications. Four tumor cell lines (A549, LNCap, MCF-7, and MDA-MB 435) were used to assess 34 samples extracted by three methods: cellulase enzyme, lysozyme enzyme and ultra-sonication. The fluorescence measurements and the recorded images alongside the spectral intensities between 650–800 nm wavelengths provided characteristic features to some of the contents of the examined extracts. Results: Several microalgae constituents activated by blue light (BL), red light (RL) or both (in sequence) exhibited significant effects on the viability of the tumor cell lines, decreasing it as much as 95% for certain MA constituents. Majority of the MA constituents showed a higher phototoxicity after exposure to both blue and red lights than the photo-induced toxicity when exposed to a single light source. The viability of the tumor cells exhibited the dose dependent response with the MA constituents. Conclusion: The results clearly showed that MA constituents are potential photosensitizers that have a significant photo-damage effects on the tested cancer cells.
AB - Background: In recent years, microalgae (MA) have attracted much interest considering their possible therapeutic application. They contain active natural compounds or derivatives (extracts, pure or chemically modified compounds) that have increasing applications in the pharmaceutical industry. Methods: The present study aims to examine microalgae for new photosensitizers, with a potential to be used in the light-associated treatment of tumors. Semi-purified extracts of several microalgae strains were evaluated as photosensitizers for photodynamic therapy (PDT) applications. Four tumor cell lines (A549, LNCap, MCF-7, and MDA-MB 435) were used to assess 34 samples extracted by three methods: cellulase enzyme, lysozyme enzyme and ultra-sonication. The fluorescence measurements and the recorded images alongside the spectral intensities between 650–800 nm wavelengths provided characteristic features to some of the contents of the examined extracts. Results: Several microalgae constituents activated by blue light (BL), red light (RL) or both (in sequence) exhibited significant effects on the viability of the tumor cell lines, decreasing it as much as 95% for certain MA constituents. Majority of the MA constituents showed a higher phototoxicity after exposure to both blue and red lights than the photo-induced toxicity when exposed to a single light source. The viability of the tumor cells exhibited the dose dependent response with the MA constituents. Conclusion: The results clearly showed that MA constituents are potential photosensitizers that have a significant photo-damage effects on the tested cancer cells.
KW - Anticancer agent
KW - Enzymatic extraction
KW - Microalgae
KW - Photodynamic therapy
KW - Photosensitizers
UR - http://www.scopus.com/inward/record.url?scp=85058241574&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058241574&partnerID=8YFLogxK
U2 - 10.1016/j.irbm.2018.11.003
DO - 10.1016/j.irbm.2018.11.003
M3 - Article
AN - SCOPUS:85058241574
SN - 1959-0318
VL - 40
SP - 51
EP - 61
JO - ITBM-RBM
JF - ITBM-RBM
IS - 1
ER -